Advertisement.

SLGL Projected Dividend Yield

Ord/Sol-Gel Technologies Ltd ( NASDAQ : SLGL )

Sol-Gel Technologies is a clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. Co.'s primary product candidate, Twyneo®, is a once-daily, non-antibiotic topical cream that it is developing for the treatment of acne vulgaris. Co.'s second branded product candidate is Epsolay®, a potential treatment for subtype II rosacea. Co.'s other branded product candidates are SGT-210, a potential treatment of palmoplantar keratoderma. Co. is also pre-clinically testing erlotinib, tapinarof and roflumilast in various new pharmaceutical indications.

20 YEAR PERFORMANCE RESULTS

SLGL Dividend History Detail
SLGL Dividend News
SLGL Competitors News

# of Shares: 0

Closing Price: 0.48

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2014	0.00	0%	0	$ 0.00	0.00%
2015	0.00	0%	0	$ 0.00	0.00%
2016	0.00	0%	0	$ 0.00	0.00%
2017	0.00	0%	0	$ 0.00	0.00%
2018	0.00	0%	0	$ 0.00	0.00%
2019	0.00	0%	0	$ 0.00	0.00%
2020	0.00	0%	0	$ 0.00	0.00%
2021	0.00	0%	0	$ 0.00	0.00%
2022	0.00	0%	0	$ 0.00	0.00%
2023	0.00	0%	0	$ 0.00	0.00%
2024	0.00	0%	0	$ 0.00	0.00%
2025	0.00	0%	0	$ 0.00	0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
Total:					0.0000